Unilink Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.60 Cr
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 23.53 Cr
- Revenue Growth 13.87%
- Profit Growth -4.66%
- Ebitda -21.75%
- Net Worth 12.29%
- Total Assets 18.84%
About Unilink Pharma
Unilink Pharma Private Limited (UPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 February 2005 and has a history of 20 years and two months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Unilink Drugs And Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.60 Cr.
The company currently has active open charges totaling ₹23.53 Cr.
Sreenivasan Karunakaran and Karunakaran Vijaya serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TN2005PTC055459
- Company No.
055459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
What products or services does Unilink Pharma Private Limited offer?
Unilink Pharma Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Alcohol Solvents, Dimethylaminoethanol DMAE.
Unilink Pharma Private Limited
Explore comprehensive data for Unilink Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Unilink Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karunakaran Vijaya  | Managing Director | 23-Feb-2005 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreenivasan Karunakaran | Whole-Time Director | 02-Oct-2009 | Current |
Financial Performance of Unilink Pharma.
Unilink Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.87% increase. The company also saw a slight decrease in profitability, with a 4.66% decrease in profit. The company's net worth Soared by an impressive increase of 12.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unilink Pharma?
In 2023, Unilink Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹23.53 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 17.89 Cr
- Others : 3.00 Cr
- Icici Bank Limited : 1.40 Cr
- Icici Home Finance Company Limited : 1.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2020 | State Bank Of India | ₹1.97 Cr | Open |
| 08 Jan 2020 | Others | ₹3.00 Cr | Open |
| 19 Mar 2014 | Icici Bank Limited | ₹1.40 Cr | Open |
| 01 Oct 2009 | Icici Home Finance Company Limited | ₹1.24 Cr | Open |
| 28 Mar 2005 | State Bank Of India | ₹15.92 Cr | Open |
How Many Employees Work at Unilink Pharma?
Unlock and access historical data on people associated with Unilink Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unilink Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unilink Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Unilink Pharma
Recent activity within the organization
- Annual General Meeting
Unilink Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Unilink Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
- Charges
A charge with State Bank Of India of Rs. 15.92 Cr registered on 28 Mar 2005 with Charge ID 80020355 was modified on 26 Mar 2024.
- Charges
A charge with State Bank Of India amounted to Rs. 1.97 Cr with Charge ID 100367338 was registered on 30 May 2020.
- Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100313511 was registered on 08 Jan 2020.
- Charges
A charge with Icici Bank Limited amounted to Rs. 1.40 Cr with Charge ID 10485266 was registered on 19 Mar 2014.
Frequently asked questions
What is the Incorporation or founding date of Unilink Pharma Private Limited?
Unilink Pharma Private Limited was incorporated on 23 Feb 2005.
What is authorized share capital and paid-up capital of Unilink Pharma Private Limited?
The authorized share capital of Unilink Pharma Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 1.60 Cr.
Who are the current board members & directors of Unilink Pharma Private Limited?
Currently 2 directors are associated with Unilink Pharma Private Limited.
- Sreenivasan Karunakaran
- Karunakaran Vijaya
What is the registered address of Unilink Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Unilink Pharma Private Limited is New No.111, Old No.23Parthasarathypuram T Nagar India, Chennai-600017., Tamil Nadu.
What is the corporate identification number (CIN) and company number of Unilink Pharma Private Limited?
The corporate identification number (CIN) of Unilink Pharma Private Limited is U24232TN2005PTC055459 and the company number is 055459 as per Ministry of Corporate Affairs (MCA).
What is the official website of Unilink Pharma Private Limited?
The Official website of Unilink Pharma Private Limited is https://www.unilinkpharma.com
What has been the recent revenue trend for Unilink Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Unilink Pharma Private Limited has risen by 13.87%.
What change has been observed in the net worth of Unilink Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Unilink Pharma Private Limited has experienced an upsurge of 12.29%.
What are the total open charges for Unilink Pharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Unilink Pharma Private Limited amount to ₹ 23.53 Cr.
When was the last Balance Sheet of Unilink Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Unilink Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
SP
Sekar PadmanWholetime DirectorDV
Donapadmanabha VenkatesanDirectorT
TpalanisamyDirectorRP
Ramkumar PalanisamyWholetime Director
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India